Author Archives: Ines Martins, PhD

Weigh advantages against possible side effects

I am just gonna call out the white elephant in the room because everyone has seen the news about drug therapies and possible side effects but no one really knows who or how this affects someone with any chronic illness let alone, for me, with lupus. Let’s be honest, we…

Aurinia and Lonza Join to Produce Voclosporin for Phase 3 Lupus Nephritis Trial, Possible Market Use

Aurinia Pharmaceuticals and Lonza have entered into a long-term manufacturing agreement over the active pharmaceutical ingredient (API) in voclosporin, Aurinia’s investigative drug for diseases that include lupus nephritis (LN). The agreement aims toward providing an eventual commercial supply of voclosporin, and includes its use in an upcoming and possibly pivotal clinical trial in LN…

East Stroudsburg University Seeks Volunteers for Lupus Study

A new research study exploring the effects of rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) on hearing, cognition, and language is calling for volunteers. The study, to be conducted at the Department of Communication Sciences and Disorders of East Stroudsburg University, aims to better understand both these…

Sex, Drugs and Rockin’ Lupus

You probably have heard the phrase “Sex, Drugs and Rock ‘n’ Roll.” I was used to hearing it as well as I grew up in the music industry in Los Angeles, with parents heavy into the ’80s rock scene. I grew up being told I was a rock star. No matter what…

AARDA Celebrates ‘Autoimmune Heroes’ on Its Scientific Advisory Board

The American Autoimmune Related Diseases Association (AARDA) recently announced its latest #AutoimmuneHeroes — its 22 Scientific Advisory Board (SAB) members who, over the past 25 years, have contributed their time and talents to advancing the association and helping it realize its goals of promoting research into lupus and other autoimmune…

Lupus Research Alliance Raises $2.5 Million at Inaugural Gala

The Lupus Research Alliance, newly formed from the merger of three different lupus groups, had its debut at the recent Inaugural Gala in New York, a fundraising event that collected over $2.5 million to support lupus research initiatives. The gala was co-hosted by Robert Wood Johnson IV, Lupus Research Alliance chairman and chief executive…